News
IBO
4.910
-4.47%
-0.230
Weekly Report: what happened at IBO last week (1109-1113)?
Weekly Report · 13h ago
Weekly Report: what happened at IBO last week (1102-1106)?
Weekly Report · 11/09 10:13
Impact Biomedical Advances to Stockholder Vote After SEC Approval
TipRanks · 11/03 14:52
DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
Barchart · 11/02 22:33
Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
Barchart · 11/02 22:25
Weekly Report: what happened at IBO last week (1026-1030)?
Weekly Report · 11/02 10:13
Impact BioMedical Sets Vote on Transformational Merger With Zoar Limited
TipRanks · 10/27 10:27
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 10/26 12:05
Weekly Report: what happened at IBO last week (1019-1023)?
Weekly Report · 10/26 10:13
Weekly Report: what happened at IBO last week (1012-1016)?
Weekly Report · 10/19 10:13
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 10/15 17:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 10/14 21:06
Weekly Report: what happened at IBO last week (1005-1009)?
Weekly Report · 10/12 10:18
Weekly Report: what happened at IBO last week (0928-1002)?
Weekly Report · 10/05 10:17
Weekly Report: what happened at IBO last week (0921-0925)?
Weekly Report · 09/28 10:13
Impact Biomedical Inc trading resumes
TipRanks · 09/23 14:10
Impact Biomedical Inc trading halted, volatility trading pause
TipRanks · 09/23 14:05
Chinese regulators slow humanoid robot IPO wave - report
Seeking Alpha · 09/21 12:31
Weekly Report: what happened at IBO last week (0914-0918)?
Weekly Report · 09/21 10:13
Upcoming Stock Splits This Week (September 21 to September 25) – Stay Invested
TipRanks · 09/20 19:00
More
Webull provides a variety of real-time IBO stock news. You can receive the latest news about Impact Biomedical, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About IBO
Impact Biomedical, Inc. is a biotechnology company engaged in discovering, developing, and patenting healthcare solutions. It discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. It has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. It also evaluates additional technologies.